Skip to main content

Advertisement

SpringerLink
Log in

Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine

  • Original Paper
  • Published:
Social Psychiatry and Psychiatric Epidemiology Aims and scope Submit manuscript

Abstract

Objective

Patient’s language, tradition, conventions, and customs may all determine integration into a society and are also part of the doctor–patient relationship that influences diagnostic and therapeutic outcome. Language barrier and sociocultural disparity of Eastern and Southern European patients may hamper recovery from pain and depression compared to Middle European patients in Switzerland.

Methods

In a prospective naturalistic observational trial we investigated the influence of regional origin on treatment outcome in 420 pain sufferers with depressive symptoms from all over Switzerland who were treated with venlafaxine by 122 physicians in primary care. Physicians rated severity of depressive symptoms using the clinical global impression severity scale and pain intensity by means of visual analogue scales. We hypothesized that in Eastern and Southern European patients the magnitude of pain reduction under treatment with venlafaxine is less compared to Middle European patients.

Results

Three months after study entry, Middle European patients were found to profit more from treatment with venlafaxine in terms of severity of depression and pain intensity than patients from Eastern Europe and Southern Europe.

Conclusion

Regional origin may contribute to the magnitude of pain reduction in patients with depressive symptoms under treatment with venlafaxine. Our results provide a rational for care provider educational programs aimed at improving capacities in treating patients from different regional origin with psychosomatic complaints such as depression and comorbid pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Reference List

  1. Adelman LC, Adelman JU, Von Seggern R, Mannix LK (2000) Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 40:572–580

    Article  CAS  PubMed  Google Scholar 

  2. Arnow BA, Hunkeler EM, Blasey CM, Lee J, Constantino MJ, Fireman B, Kraemer HC, Dea R, Robinson R, Hayward C (2006) Comorbid depression, chronic pain, and disability in primary care. Psychosom Med 68:262–268

    Article  PubMed  Google Scholar 

  3. Bair MJ, Robinson RL, Eckert GJ, Stang PE, Croghan TW, Kroenke K (2004) Impact of pain on depression treatment response in primary care. Psychosom Med 66:17–22

    Article  PubMed  Google Scholar 

  4. Bair MJ, Robinson RL, Katon W, Kroenke K (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163:2433–2445

    Article  PubMed  Google Scholar 

  5. Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ (2006) What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder? J Clin Psychiatry 67:1428–1434

    Article  PubMed  Google Scholar 

  6. Bates MS, Edwards WT, Anderson KO (1993) Ethnocultural influences on variation in chronic pain perception. Pain 52:101–112

    Article  CAS  PubMed  Google Scholar 

  7. Begré S, Traber M, Gerber M, von Kaenel R (2008) Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care. Eur Psychiatry 23(3):178–186

    Article  PubMed  Google Scholar 

  8. Cutrona CE, Russell DW, Brown PA, Clark LA, Hessling RM, Gardner KA (2005) Neighborhood context, personality, and stressful life events as predictors of depression among African American women. J Abnorm Psychol 114:3–15

    Article  PubMed  Google Scholar 

  9. Eisenman DP, Gelberg L, Liu H, Shapiro MF (2003) Mental health and health-related quality of life among adult Latino primary care patients living in the United States with previous exposure to political violence. JAMA 290:627–634

    Article  PubMed  Google Scholar 

  10. Fillingim RB (2005) Individual differences in pain responses. Curr Rheumatol Rep 7:342–347

    Article  PubMed  Google Scholar 

  11. Freeman EW, Rickels K, Yonkers KA, Kunz NR, McPherson M, Upton GV (2001) Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol 98:737–744

    Article  CAS  PubMed  Google Scholar 

  12. Geerlings SW, Twisk JW, Beekman AT, Deeg DJ, van Tilburg W (2002) Longitudinal relationship between pain and depression in older adults: sex, age and physical disability. Soc Psychiatry Psychiatr Epidemiol 37:23–30

    Article  PubMed  Google Scholar 

  13. Gilgen D, Gross CS, Maeusezahl D, Frey C, Tanner M, Weiss MG, Hatz C (2002) Impact of organized violence on illness experience of Turkish/Kurdish and Bosnian migrant patients in primary care. J Travel Med 9:236–240

    PubMed  Google Scholar 

  14. Greenberg PE, Leong SA, Birnbaum HG, Robinson RL (2003) The economic burden of depression with painful symptoms. J Clin Psychiatry 64(Suppl 7):17–23

    PubMed  Google Scholar 

  15. Guy W (1976) ECDEU assessment manual for psychopharmacology (rev edn). National Institute for Mental Health, Rockville

    Google Scholar 

  16. Karp JF (2004) Venlafaxine XR and chronic pelvic pain syndrome. J Clin Psychiatry 65:880–881

    Article  PubMed  Google Scholar 

  17. Leyer EM (1990) Hidden interpersonal structures in medical and psychotherapy interaction with foreign patients—presented and discussed with the example of a Turkish patient with chronic pain. Psychother Psychosom Med Psychol 40:423–431

    CAS  PubMed  Google Scholar 

  18. Lin EH, Katon WJ, Simon GE, Von Korff M, Bush TM, Walker EA, Unutzer J, Ludman EJ (2000) Low-intensity treatment of depression in primary care: is it problematic? Gen Hosp Psychiatry 22:78–83

    Article  CAS  PubMed  Google Scholar 

  19. Lynch ME (2001) Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci 26:30–36

    CAS  PubMed  Google Scholar 

  20. Mbaya P (2002) Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression. Hum Psychopharmacol 17:335–339

    Article  CAS  PubMed  Google Scholar 

  21. McCrae JD, Lumley MA (1998) Health status in sickle cell disease: examining the roles of pain coping strategies, somatic awareness, and negative affectivity. J Behav Med 21:35–55

    Article  CAS  PubMed  Google Scholar 

  22. Reuben SS (2005) The prevention of post-surgical neuralgia. Pain 113:242–243

    Article  PubMed  Google Scholar 

  23. Rudolph RL, Fabre LF, Feighner JP, Rickels K, Entsuah R, Derivan AT (1998) A randomized, placebo-controlled, dose–response trial of venlafaxine hydrochloride in the treatment of major depression. J Clin Psychiatry 59:116–122

    CAS  PubMed  Google Scholar 

  24. Sabbioni ME, Eugster S (2001) Interactions of a history of migration with the course of pain disorder. J Psychosom Res 50:267–269

    Article  CAS  PubMed  Google Scholar 

  25. Sayar K, Aksu G, Ak I, Tosun M (2003) Venlafaxine treatment of fibromyalgia. Ann Pharmacother 37:1561–1565

    Article  CAS  PubMed  Google Scholar 

  26. Schouten BC, Meeuwesen L (2006) Cultural differences in medical communication: a review of the literature. Patient Educ Couns 64:21–34

    Article  PubMed  Google Scholar 

  27. Songer DA, Schulte H (1996) Venlafaxine for the treatment of chronic pain. Am J Psychiatry 153:737

    CAS  PubMed  Google Scholar 

  28. Ulusahin A, Basoglu M, Paykel ES (1994) A cross-cultural comparative study of depressive symptoms in British and Turkish clinical samples. Soc Psychiatry Psychiatr Epidemiol 29:31–39

    CAS  PubMed  Google Scholar 

  29. Weilburg JB, O’Leary KM, Meigs JB, Hennen J, Stafford RS (2003) Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv 54:1233–1239

    Article  PubMed  Google Scholar 

  30. Williams LS, Jones WJ, Shen J, Robinson RL, Kroenke K (2004) Outcomes of newly referred neurology outpatients with depression and pain. Neurology 63:674–677

    CAS  PubMed  Google Scholar 

  31. Yucel A, Ozyalcin S, Koknel TG, Kiziltan E, Yucel B, Andersen OK, Arendt-Nielsen L, Disci R (2005) The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study. Eur J Pain 9:407–416

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

We are grateful to Wyeth Pharmaceuticals AG, Switzerland for providing its data pool to perform this study.

Author information

Authors and Affiliations

  1. Division of Psychosomatic Medicine, Department of General Internal Medicine, University Hospital/Inselspital, 3010, Bern, Switzerland

    Stefan Begré & Roland von Känel

  2. Wyeth Pharmaceuticals AG, Grafenauweg 10, Zug, Switzerland

    Martin Traber

  3. GEM Clinical Research Consulting M. Gerber, Gewerbestrasse 6, Unterägeri/ZG, Switzerland

    Martin Gerber

Authors
  1. Stefan Begré
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Traber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Gerber
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roland von Känel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Begré.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Begré, S., Traber, M., Gerber, M. et al. Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine. Soc Psychiat Epidemiol 45, 17–24 (2010). https://doi.org/10.1007/s00127-009-0036-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00127-009-0036-2

Keywords

Search

Navigation